Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: A comparison of African and white Americans

Obesity Research

Volumn 8, Issue 1, 2000, Pages 62-70

  MacLean, Paul S ^a   Bower, Joseph F ^a   Vadlamudi, Satyaprasad ^a   Green, Thomas ^a   Barakat, Hisham A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

CETP; HDL; LDL; NMR spectroscopy; VLDL

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD; BODY MASS; CAUCASIAN; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MIDDLE AGED; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, VLDL; MIDDLE AGED; OBESITY; TRIGLYCERIDES;

EID: 0033632040     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2000.9     Document Type: Article

References (35)

1. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260: 1917-21.
2. Campos H, Genest JJ Jr, Blijlevens E, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-95.
3. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276: 875-81.
4. Griffin BA, Freeman DJ, Taait GW, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106:241-53.
5. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-8.
6. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:1046-53.
7. Wilson HM, Patel JC, Russe D, Skinner ER. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma of high density lipoprotein in coronary heart disease. Clin Chim Acta. 1993;220:175-87.
8. Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoproteins and coronary atherosclerosis: a strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb. 1991; 11:174-82.
9. 2 cholesterol with coronary heart disease in noninsulin-dependent diabetics. Arteriosclerosis. 1985; 5:653-8.
10. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease. N Engl J Med. 1990;322:882-9.
11. Abbott RD, Donahue RP, Kannel WB, Wilson WF. The impact of diabetes on survival following myocardial infarction in men vs. women. JAMA. 1988;260:3456-60.
12. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;24:2035-8.
13. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes. 1990;39:1527-33.
14. Barakat HA, McLendon VD, Marks R, Pories W, Heath J, Carpenter JW. Influence of morbid obesity and non-insulin-dependent diabetes mellitus on high-density lipoprotein composition and subpopulation distribution. Metabolsim. 1992;41: 37-41.
15. Dawson DA. Ethnic differences in female overweight: data from the 1985 National Health Interview Survey. Am J Public Health. 1988;129:1376-9.
16. Kuczmarski RJ, Flegel KM, Campbell SM, Johnson CL. Increased prevalence of overweight among U.S. adults. The National Health & Nutrition Examination Survey. 1960 to 1961. JAMA. 1994;272:205-11.
17. Lipton RB, Liao Y, Cao G, Cooper RS, McGee D. Determinants of incident non-insulin dependent diabetes mellitus among blacks and whites in a national sample: The NHANES I Epidemiological Follow-up Study. Am J Epidemiol. 1993; 138:826-39.
18. Folsom AR, Stevens J, Schreiner PJ, McGovern PG. Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites. Am J Epidemiol. 1998;148:1187-94.
19. Tull ES, Roseman JM. Diabetes in African Americans. In: Diabetes in America, 2nd ed. Bethesda, MD: National Institutes of Health; 1995:613-25.
20. Dowling HJ, Pi-Sunyer FX. Race-dependent health risks of upper body obesity. Diabetes. 1993;42:537-43.
21. Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African-Americans and whites with non-insulin dependent diabetes in the US population. Circulation. 1994;1690:1185-91.
22. Conway JM, Yanovski SZ, Avila NA, Hubbard VS. Visceral adipose tissue differences in black and white women. Am J Clin Nutr. 1995;61:765-71.
23. Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Diabetes Care. 1997;20:745-52.
24. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race-related health risks in obese nondiabetic premenopausal women. Diabetes. 1997;46:456-62.
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97.
26. Vadlamudi S, MacLean P, Green T, et al. Role of female sex steroids in regulating cholesteryl ester transfer protein in transgenic mice. Metabolism. 1998;47:1048-51.
27. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem. 1992;38:1632-8.
28. Otvos, JD. Measurement of lipoprotein subclass profiles by NMR spectroscopy. In: Rifai et al., eds. Handbook of Lipoprotein Testing. Washington, DC: AACC Press; 1997, pp. 497-508.
29. Otvos J, Jeyarajah E, Bennett D. A spectroscopic approach to lipoprotein subclass analysis. J Clin Ligand Assay. 1996; 19:184-9.
30. O'Neal D, Harrip P, Dragicevic G, Rae D, Best JD. A comparison of LDL size determination using gradient gel electrophoresis and light scattering methods. J Lipid Res. 1998;39:2086-90.
31. Ama PFM, Poehlman ET, Simoneau JA, et al. Fat distribution and adipose tissue metabolism in nonobese male black African and Caucasian subjects. Int J Obes. 1986;10:503-10.
32. Taskinen MR, Kuusi T, Helve E, Nikkilä EA, Yki-Järvinen H. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin dependent diabetes. Arteriosclerosis. 1988;8:168-77.
33. Bruce C, Chouinard RA, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr. 1998;18:297-330.
34. Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest. 1994;24: 188-94.
35. Syvanne M, Ahola M, Lahdenpera S, et al. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res. 1995;36: 573-82.